Institutional investors increase stakes in Cardinal Health, surpassing Q1 EPS estimate.

Institutional investors including Natixis Advisors L.P. have increased their stakes in Cardinal Health, Inc. (CAH), with a consensus rating of "Moderate Buy" and an average target price of $105.79. Cardinal Health reported Q1 earnings of $2.08 EPS, surpassing the consensus estimate of $1.95. The company operates across the United States, Canada, Europe, Asia, and internationally, providing healthcare services and products to various healthcare sectors.